Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity

Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity

Currently available COVID-19 vaccines include inactivated virus, live attenuated virus, mRNA-based, viral vectored and adjuvanted protein-subunit-based vaccines. All of them contain the spike glycoprotein as the main immunogen and result in reduced disease severity upon SARS-CoV-2 infection. While w...

Descrizione completa

Dettagli Bibliografici
Autori principali: Larissa Henze, Julian Braun, Lil Meyer-Arndt, Karsten Jürchott, Maike Schlotz, Janine Michel, Marica Grossegesse, Maike Mangold, Manuela Dingeldey, Beate Kruse, Pavlo Holenya, Norbert Mages, Ulf Reimer, Maren Eckey, Karsten Schnatbaum, Holger Wenschuh, Bernd Timmermann, Florian Klein, Andreas Nitsche, Claudia Giesecke-Thiel, Lucie Loyal, Andreas Thiel
Natura: Articolo
Lingua:English
Pubblicazione: Frontiers Media S.A. 2023-01-01
Serie:Frontiers in Immunology
Soggetti:
SARS-CoV-2
antigen-specific T-cells
cross-reactivity
heterologous vaccination
humoral response
Accesso online:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1056525/full

Accesso online

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1056525/full

Documenti analoghi